Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Life Science Alliance|June 21, 2024
p53 ensures the normal behavior and modification of G1/S-specific histone H3.1 in the nucleusTsukasa Oikawa, Junya Hasegawa, Haruka Handa, et al.
Experimental Dermatology|September 24, 2020
Type XVII collagen interacts with the aPKC-PAR complex and maintains epidermal cell polarityMika Watanabe, Hideyuki Kosumi, Shin-Ichi Osada, et al.
The Journal of Biological Chemistry|September 28, 2006
The RAC binding domain/IRSp53-MIM homology domain of IRSp53 induces RAC-dependent membrane deformationShiro Suetsugu, Kazutaka Murayama, Ayako Sakamoto, et al.
Nature Communications|February 9, 2016
Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancerShigeru Hashimoto, Shuji Mikami, Hirokazu Sugino, et al.
The Journal of Cell Biology|April 6, 2016
P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistanceAri Hashimoto, Tsukasa Oikawa, Shigeru Hashimoto, et al.
Plos One|January 25, 2015
A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclastsMaiko Matsushita, Yoshie Ozaki, Yuka Hasegawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2019
ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancerShigeru Hashimoto, Shotaro Furukawa, Ari Hashimoto, et al.
Pageof 3